Sökning: onr:"swepub:oai:DiVA.org:uu-489114" >
Vitamin D and bone ...
-
Khamisi, SelwanUppsala universitet,Endokrinologi och mineralmetabolism,Uppsala Univ Hosp, Dept Endocrinol & Diabet, S-75185 Uppsala, Sweden.
(författare)
Vitamin D and bone metabolism in Graves’ disease : a prospective study
- Artikel/kapitelEngelska2023
Förlag, utgivningsår, omfång ...
-
2022-09-27
-
Springer,2023
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-489114
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-489114URI
-
https://doi.org/10.1007/s40618-022-01927-yDOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Purpose Vitamin D and osteoporosis in Graves' disease (GD) have been examined in cross-sectional studies with divergent results. Here, we prospectively studied vitamin D metabolism and bone health in patients with newly diagnosed GD. Methods Thirty consecutive patients with de novo overt thyrotoxicosis diagnosed with GD were included. At diagnosis, none of the patients were treated with vitamin D or anti-osteoporotic drugs. All patients were initially treated with antithyroid drugs. Blood samplings were taken at baseline and at 6 weeks, 3, 6, 12 and 24 months after treatment start. Serum levels of 25OHD3, 1,25OH2D3, calcium, parathyroid hormone (PTH), and C-terminal telopeptides of Type I collagen (CTX-I) were analysed. Bone mineral density (BMD) was measured at baseline, and 1 and 2 years after treatment initiation. Results At diagnosis, patients with GD did not have vitamin D deficiency. There were no significant correlations between levels of 25OHD3 and thyrotoxicosis. Upon treatment of the thyrotoxicosis, serum calcium fell transiently, and PTH and 1,25OH2D3 increased. 25OHD3 fell within the normal range and stabilised at 6 months. CTX-I fell over 12 months, BMD increased significantly up to 2 years, p = 0.002, < 0.001 and 0.005 in the spine, left total hip and left femoral neck, respectively. Conclusions The present data underline that thyrotoxicosis has a negative impact on bone health and demonstrate fine-tuned dynamics in bone and vitamin D metabolism. Upon treatment, bone health improved over a follow-up period of 24 months despite rising PTH. Increased conversion of 25OHD3 to 1,25OH2D3 occurs during treatment of GD.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Lundqvist, Martin H.Uppsala universitet,Klinisk diabetologi och metabolism,Uppsala Univ Hosp, Dept Endocrinol & Diabet, S-75185 Uppsala, Sweden.(Swepub:uu)marlu858
(författare)
-
Rasmusson, Annica J.Uppsala universitet,Klinisk farmakogenomik och osteoporos(Swepub:uu)annijaco
(författare)
-
Edén Engström, BrittUppsala universitet,Endokrinologi och mineralmetabolism,Uppsala Univ Hosp, Dept Endocrinol & Diabet, S-75185 Uppsala, Sweden.(Swepub:uu)brittee
(författare)
-
Karlsson, F. A.Uppsala universitet,Institutionen för medicinska vetenskaper,Uppsala Univ Hosp, Dept Endocrinol & Diabet, S-75185 Uppsala, Sweden.
(författare)
-
Ljunggren, ÖstenUppsala universitet,Endokrinologi och mineralmetabolism,Uppsala Univ Hosp, Dept Endocrinol & Diabet, S-75185 Uppsala, Sweden.(Swepub:uu)osteljun
(författare)
-
Uppsala universitetEndokrinologi och mineralmetabolism
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Journal of Endocrinological Investigation: Springer46, s. 425-4330391-40971720-8386
Internetlänk
Hitta via bibliotek
Till lärosätets databas